Stocks and Investing Stocks and Investing
Tue, April 2, 2024

Raghuram Selvaraju Maintained (AXSM) at Strong Buy and Held Target at $190 on, Apr 2nd, 2024


Published on 2024-10-28 10:02:32 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $190 on, Apr 2nd, 2024.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 9 other peers that have a rating on AXSM. Out of the 9 peers that are also analyzing AXSM, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 9 analyists that currently disagree with Raghuram


  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $109 on, Thursday, March 28th, 2024
  • Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $150 on, Tuesday, March 26th, 2024
  • Leonid Timashev of "RBC Capital" Maintained at Buy with Increased Target to $128 on, Tuesday, March 26th, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Increased Target to $127 on, Tuesday, March 26th, 2024
  • Joel Beatty of "Baird" Initiated at Buy and Held Target at $108 on, Tuesday, March 19th, 2024
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $125 on, Wednesday, February 21st, 2024
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $103 on, Wednesday, February 21st, 2024
  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024
  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024
Contributing Sources